Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia
β Scribed by A.F.Y. Al Hadithy; S.A. Ivanova; P. Pechlivanoglou; A. Semke; O. Fedorenko; E. Kornetova; L. Ryadovaya; J.R.B.J. Brouwers; B. Wilffert; R. Bruggeman; A.J.M. Loonen
- Book ID
- 116841509
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 198 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0278-5846
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Neuronal degeneration due to oxidative stress (OS) has been proposed as a mechanism for tardive dyskinesia (TD) pathogenesis. Cellular defense mechanisms against OS may involve detoxification enzymes (e.g., glutathione peroxidaseβ1, GPX1; superoxide dismutaseβ2, SOD2 [also commonly know
## Abstract ## Objective This study seeks to replicate previous results indicating that T102C in the serotonin 2A receptor (HTR2A) and Ser9Gly in the dopamine D3 receptor (DRD3) were associated with a risperidone response to acutely exacerbated schizophrenia, and to determine whether possession of